{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:53:15Z","timestamp":1781639595779,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute macular neuroretinopathy (AMN), a rare retinal disorder, is characterized by mild visual impairment that is associated with macular lesions. AMN cases increased during the coronavirus disease 2019 (COVID-19) pandemic. Chinese ophthalmology clinics have also observed an increase in cases since the end of 2022. We analyzed the clinical and epidemiological characteristics of COVID-19-related AMN cases in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included 90 patients (152 eyes). Information regarding COVID-19-related AMN cases was collected from online consultations and local clinics. Cases were diagnosed using multimodal fundus imaging. Statistical analyses were performed to evaluate clinical features and prognostic characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Most patients were female (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200970; 78%) and young (mean age, 28.6\u2009\u00b1\u20096.0 years). Bilateral AMN lesions were observed in 69% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200962) of patients. Most patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200979; 88%) experienced a peak in ocular symptoms on the second to third day after COVID-19 symptoms, following a high fever. The most common ocular symptom was scotomas (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200963 eyes; 41%). Most eyes (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009112; 74%) had a baseline best-corrected visual acuity of \u2265\u200920\/40. Among 56 patients (96 eyes) with follow-up durations of 3\u201315 months, changes in patient-reported visual symptoms were observed, with improvement in 41% of eyes (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200939), no change in 46% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200944), and worsening in 13% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200913).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Recognizing and addressing COVID-19-related retinal complications, particularly AMN, are important. Follow-up is crucial for monitoring the progression and evolution of visual symptoms and retinal changes over time.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-026-00825-2","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T16:03:47Z","timestamp":1772294627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["COVID-19-related acute macular neuroretinopathy in China: a retrospective study of 90 cases (152 eyes)"],"prefix":"10.1186","volume":"12","author":[{"given":"Hua","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boya","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiannan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialiang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"825_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/0002-9394(75)90387-6","volume":"80","author":"PJ Bos","year":"1975","unstructured":"Bos PJ, Deutman AF. Acute macular neuroretinopathy. Am J Ophthalmol. 1975;80:573\u201384. https:\/\/doi.org\/10.1016\/0002-9394(75)90387-6.","journal-title":"Am J Ophthalmol"},{"key":"825_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000533530","volume":"246","author":"E Premi","year":"2023","unstructured":"Premi E, Acampora R, Salmi D, Ilie I, Pagnoncelli N, Germano F, et al. Clinical and diagnostic findings of acute macular neuroretinopathy and paracentral acute middle maculopathy in the COVID-19 era. Ophthalmologica. 2023;246:181\u201391. https:\/\/doi.org\/10.1159\/000533530.","journal-title":"Ophthalmologica"},{"key":"825_CR3","doi-asserted-by":"publisher","first-page":"100002","DOI":"10.1016\/j.jfop.2023.100002","volume":"1","author":"S Koksaldi","year":"2023","unstructured":"Koksaldi S, Saatci AO. Bilateral acute macular neuroretinopathy in association with recent COVID-19 infection. JFO Open Ophthalmol. 2023;1:100002. https:\/\/doi.org\/10.1016\/j.jfop.2023.100002.","journal-title":"JFO Open Ophthalmol"},{"key":"825_CR4","doi-asserted-by":"publisher","first-page":"100103","DOI":"10.1016\/j.apjo.2024.100103","volume":"13","author":"X Song","year":"2024","unstructured":"Song X, Yu Y, Zhou H, Zhang Y, Mao Y, Wang H, et al. Acute macular neuroretinopathy associated with COVID-19 pandemic: a real-world observation study. Asia Pac J Ophthalmol (Phila). 2024;13:100103. https:\/\/doi.org\/10.1016\/j.apjo.2024.100103.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"825_CR5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.survophthal.2016.03.003","volume":"61","author":"KV Bhavsar","year":"2016","unstructured":"Bhavsar KV, Lin S, Rahimy E, Joseph A, Freund KB, Sarraf D, et al. Acute macular neuroretinopathy: a comprehensive review of the literature. Surv Ophthalmol. 2016;61:538\u201365. https:\/\/doi.org\/10.1016\/j.survophthal.2016.03.003.","journal-title":"Surv Ophthalmol"},{"key":"825_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0039-6257(02)00398-3","volume":"48","author":"SD Turbeville","year":"2003","unstructured":"Turbeville SD, Cowan LD, Gass JD. Acute macular neuroretinopathy: a review of the literature. Surv Ophthalmol. 2003;48:1\u201311. https:\/\/doi.org\/10.1016\/s0039-6257(02)00398-3.","journal-title":"Surv Ophthalmol"},{"key":"825_CR7","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1001\/jamaophthalmol.2015.2687","volume":"133","author":"M Li","year":"2015","unstructured":"Li M, Zhang X, Ji Y, Ye B, Wen F. Acute macular neuroretinopathy in dengue fever: short-term prospectively followed up case series. JAMA Ophthalmol. 2015;133:1329\u201333. https:\/\/doi.org\/10.1001\/jamaophthalmol.2015.2687.","journal-title":"JAMA Ophthalmol"},{"key":"825_CR8","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1038\/s41433-020-1069-8","volume":"34","author":"J Virgo","year":"2020","unstructured":"Virgo J, Mohamed M. Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection. Eye (Lond). 2020;34:2352\u20133. https:\/\/doi.org\/10.1038\/s41433-020-1069-8.","journal-title":"Eye (Lond)"},{"key":"825_CR9","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1038\/s41433-021-01752-2","volume":"36","author":"A Diafas","year":"2022","unstructured":"Diafas A, Ghadiri N, Beare N, Madhusudhan S, Pearce I, Tan SZ. Correction to: comment on: Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection. Eye (Lond). 2022;36:1522. https:\/\/doi.org\/10.1038\/s41433-021-01752-2.","journal-title":"Eye (Lond)"},{"key":"825_CR10","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.3390\/jcm10215038","volume":"10","author":"G Azar","year":"2021","unstructured":"Azar G, Bonnin S, Vasseur V, Faure C, Salviat F, Clermont CV, et al. Did the COVID-19 pandemic increase the incidence of acute macular neuroretinopathy? J Clin Med. 2021;10:5038. https:\/\/doi.org\/10.3390\/jcm10215038.","journal-title":"J Clin Med"},{"key":"825_CR11","doi-asserted-by":"publisher","first-page":"taad109","DOI":"10.1093\/jtm\/taad109","volume":"30","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Liu Y, Gao Y, Man S, Mou K, Xu H, et al. An alarming rise in COVID-19-related acute macular neuroretinopathy in China: a cross-sectional multimodal imaging study. J Travel Med. 2023;30:taad109. https:\/\/doi.org\/10.1093\/jtm\/taad109.","journal-title":"J Travel Med"},{"key":"825_CR12","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.2147\/JIR.S413050","volume":"16","author":"B Xu","year":"2023","unstructured":"Xu B, Zhang J, Zhang Y, Cheng Y, Huang Q. Transient increase in patient numbers with acute macular neuroretinopathy post SARS-CoV-2 infection: case series during the first surge of infection in December 2022. J Inflamm Res. 2023;16:2763\u201371. https:\/\/doi.org\/10.2147\/JIR.S413050.","journal-title":"J Inflamm Res"},{"key":"825_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ajo.2021.07.004","volume":"236","author":"C Iovino","year":"2022","unstructured":"Iovino C, Au A, Ramtohul P, Bacci T, AlBahlal A, Khan AM, et al. Coincident PAMM and AMN and insights into a common pathophysiology. Am J Ophthalmol. 2022;236:136\u201346. https:\/\/doi.org\/10.1016\/j.ajo.2021.07.004.","journal-title":"Am J Ophthalmol"},{"key":"825_CR14","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1097\/IAE.0b013e318263d0c3","volume":"32","author":"AA Fawzi","year":"2012","unstructured":"Fawzi AA, Pappuru RR, Sarraf D, Le PP, McCannel CA, Sobrin L, et al. Acute macular neuroretinopathy: long-term insights revealed by multimodal imaging. Retina. 2012;32:1500\u201313. https:\/\/doi.org\/10.1097\/IAE.0b013e318263d0c3.","journal-title":"Retina"},{"key":"825_CR15","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/ajh.25982","volume":"95","author":"TC Hanff","year":"2020","unstructured":"Hanff TC, Mohareb AM, Giri J, Cohen JB, Chirinos JA. Thrombosis in COVID-19. Am J Hematol. 2020;95:1578\u201389. https:\/\/doi.org\/10.1002\/ajh.25982.","journal-title":"Am J Hematol"},{"key":"825_CR16","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","volume":"11","author":"AM Baig","year":"2020","unstructured":"Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host\u2013virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11:995\u20138. https:\/\/doi.org\/10.1021\/acschemneuro.0c00122.","journal-title":"ACS Chem Neurosci"},{"key":"825_CR17","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.ajpath.2023.02.016","volume":"193","author":"HN Sen","year":"2023","unstructured":"Sen HN, Vannella KM, Wang Y, Chung JY, Kodati S, Ramelli SC, et al. Histopathology and SARS-CoV-2 cellular localization in eye tissues of COVID-19 autopsies. Am J Pathol. 2023;193:1809\u201316. https:\/\/doi.org\/10.1016\/j.ajpath.2023.02.016.","journal-title":"Am J Pathol"},{"key":"825_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/pgmj.72.849.409","volume":"72","author":"SA Buckley","year":"1996","unstructured":"Buckley SA, James B. Purtscher\u2019s retinopathy. Postgrad Med J. 1996;72:409\u201312. https:\/\/doi.org\/10.1136\/pgmj.72.849.409.","journal-title":"Postgrad Med J"},{"key":"825_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.survophthal.2005.12.003","volume":"51","author":"A Agrawal","year":"2006","unstructured":"Agrawal A, McKibbin MA. Purtscher\u2019s and Purtscher-like retinopathies: a review. Surv Ophthalmol. 2006;51:129\u201336. https:\/\/doi.org\/10.1016\/j.survophthal.2005.12.003.","journal-title":"Surv Ophthalmol"},{"key":"825_CR20","doi-asserted-by":"publisher","first-page":"762609","DOI":"10.3389\/fmed.2022.762609","volume":"9","author":"J Duan","year":"2022","unstructured":"Duan J, An J, Li M, Zhang Z, Zhou L, Yin P, et al. Topographical relationship between acute macular neuroretinopathy and choroidal watershed zone or patchy choroidal filling. Front Med (Lausanne). 2022;9:762609. https:\/\/doi.org\/10.3389\/fmed.2022.762609.","journal-title":"Front Med (Lausanne)"},{"key":"825_CR21","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.2147\/OPTH.S35854","volume":"6","author":"Y Hashimoto","year":"2012","unstructured":"Hashimoto Y, Saito W, Fujiya A, Noda K, Ishida S. Increased macular choroidal blood flow velocity during systemic corticosteroid therapy in a patient with acute macular neuroretinopathy. Clin Ophthalmol. 2012;6:1645\u20139. https:\/\/doi.org\/10.2147\/OPTH.S35854.","journal-title":"Clin Ophthalmol"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-026-00825-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00825-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00825-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:06:44Z","timestamp":1781636804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40942-026-00825-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["825"],"URL":"https:\/\/doi.org\/10.1186\/s40942-026-00825-2","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Second Hospital of Hebei Medical University (no. 2024-R544). The study adhered to the tenets of the Declaration of Helsinki. Written or electronic informed consent for publication of identifying information (including images and other personal or clinical details) was obtained from all participants (or their legal guardians), and efforts have been made to anonymize such details wherever possible.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}